[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370186-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370186-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","iron-metabolism-in-a-mouse-model-of-hepatocellular-carcinoma","Iron metabolism in a mouse model of hepatocellular carcinoma","","Hepatocellular carcinoma (HCC) is modeled in p53-deficient mice to investigate how iron metabolism changes during liver carcinogenesis. A transcriptome approach identifies p53-dependent gene signatures, followed by local and systemic analyses of iron metabolic parameters. Mutant mice develop liver cancer by 36 weeks, showing a local iron-poor phenotype with high Tfr1 and low hepcidin (Hamp). Systemic iron deficiency occurs in females, and tumorigenesis links to deficits in selenium, zinc, and manganese, with poor prognosis in mice and patients.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/iron-metabolism-in-a-mouse-model-of-hepatocellular-carcinoma/370186/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/iron-metabolism-in-a-mouse-model-of-hepatocellular-carcinoma/370186.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What mouse model is used to study hepatocellular carcinoma and iron metabolism?","Question",{"text":63,"@type":64},"The study uses liver-specific p53-deficient mice and chronic carbon tetrachloride injections to induce fibrosis, cirrhosis, and subsequent carcinogenesis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What iron phenotype is observed in p53-deficient liver cancers?",{"text":68,"@type":64},"All mutant mice show a local iron-poor phenotype characterized by high transferrin receptor 1 (Tfr1) and low hepcidin (Hamp).",{"name":70,"@type":61,"acceptedAnswer":71},"How do iron metabolism changes relate to prognosis?",{"text":72,"@type":64},"Iron deficiency in p53-deficient liver cancers is associated with alterations in Hamp and Tfr1 and with a poor prognosis in mice and patients.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370186,1790230638,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIron metabolism in a mouse model of hepatocellular carcinoma  \nDilayYilmaz1,5, Umesh Tharehalli2,5, Rossana Paganoni1, Paul Knoop1, Andreas Gruber3, Yuexin Chen2, Rui Dong2, Frank Leithäuser4, Thomas Seufferlein2, Kerstin Leopold3, André Lechel2,5􀀍 & Maja Vujić Spasić1,5􀀍  \nHepatocellular carcinoma (HCC) remains the most prevalent type of primary liver cancer worldwide. p53 is one of the most frequently mutated tumor-suppressor genes in HCC and its deficiency in hepatocytes triggers tumor formation in mice. To investigate iron metabolism during liver carcinogenesis, we employed a model of chronic carbon tetrachloride injections in liver-specific  \np53-deficient mice to induce liver fibrosis, cirrhosis and subsequent carcinogenesis. A transcriptome analysis of liver carcinoma was employed to identify p53-dependent gene expression signatures with subsequent in-depth analysis of iron metabolic parameters being conducted locally within liver cancersand at systemic levels. We show that all mutant mice developed liver cancer by 36-weeks of age in contrast to 3.4% tumors identified in control mice. All liver cancers with a p53-deficient background exhibited a local iron-poor phenotype with a “high transferrin receptor 1 (Tfr1) and low hepcidin (Hamp)” signature. At systemic levels, iron deficiency was restricted to female mice. Additionally, liver tumorigenesis correlated with selective deficits of selenium, zinc and manganese. Our data show that iron deficiency is a prevalent phenomenon in p53-deficient liver cancers, which is associated with alterations in Hamp and Tfr1 and a poor prognosis in mice and patients.  \nKeywords Iron metabolism, Trace elements, Liver cancer, Hepcidin, Transferrin receptor, p53  \nLiver cancer is the sixth most frequently diagnosed type of cancer and the third leading cause of cancer-related mortality worldwide1. The most common type of primary liver cancer is the hepatocellular carcinoma (HCC), which accounts for 75–85% of all liver cancers and more than 800,000 deaths/year worldwide1–3.  \nFindings from studies on whole-genome and the exome sequencing of 243 human liver tumors identified the TP53 (Trp53 in mice; short p53) as the most commonly mutated tumor suppressor gene in HCC samples and the p53 pathway being affected in half of HCC patients4–6. The importance of p53 as a tumor suppressor is evident by its ability to act as a transcription factor to regulate the expression of a series of target genes necessary for cell survival and death7. Mutated p53 is accumulated in the nuclei of transformed cells and is associated with a poor prognosis in HCC8,9. Preclinical animal models revealed that liver-specific deletion of p53 in mice led to tumor formation, demonstrating that p53 deficiency, as a single genetic lesion, induced liver tumors with high penetrance10. Interestingly, p53 deletion was not sufficient to induce tumors in the brain and intestine, indicating organ-specific differences concerning the role ofp53 in tumor development11, 12.  \nEmerging evidence indicates that deregulation of p53 leads to several metabolic disorders that are pivotal during cancer progression (reviewed in13). Importantly, p53 was shown to regulate several key components of iron metabolism14–18 and, vice versa, p53 activities were modulated by intracellular iron levels and heme14, 15, 17, 19. For example, studies performed in human hepatoma HepG2 cell line showed that p53 activation correlated with the induction of iron hormone hepcidin, and that p53 controlled hepcidin transcription by binding to putative p53-responsive elements in the promoter of the hepcidin (Hamp) gene (at position-435/-413 bp)17. Hepcidincan thus be activated by p53 and abated when p53 is silenced in vitro17. So far, no studies have yet corroborated p53-mediated hepcidin regulation in vivo. Considerably less is known regarding the mechanisms by which p53 coordinates iron met","cbCaib2lstfFpmzz","https://ap.wps.com/l/cbCaib2lstfFpmzz","pdf",5433616,13,"English","# Background\n## p53 deficiency and liver cancer models\n## p53–iron metabolism interplay\n# Methods and Experimental Design\n## Chronic carbon tetrachloride injections\n## Transcriptome and iron parameter analyses\n# Findings\n## Tumor development and penetrance\n## Local iron-poor phenotype (Tfr1/Hamp)\n## Systemic sex-specific iron deficiency\n## Correlation with selenium, zinc, and manganese deficits\n# Significance","[{\"question\":\"What mouse model is used to study hepatocellular carcinoma and iron metabolism?\",\"answer\":\"The study uses liver-specific p53-deficient mice and chronic carbon tetrachloride injections to induce fibrosis, cirrhosis, and subsequent carcinogenesis.\"},{\"question\":\"What iron phenotype is observed in p53-deficient liver cancers?\",\"answer\":\"All mutant mice show a local iron-poor phenotype characterized by high transferrin receptor 1 (Tfr1) and low hepcidin (Hamp).\"},{\"question\":\"How do iron metabolism changes relate to prognosis?\",\"answer\":\"Iron deficiency in p53-deficient liver cancers is associated with alterations in Hamp and Tfr1 and with a poor prognosis in mice and patients.\"}]","Iron metabolism in a mouse model of hepatocellular carcinoma | PDF",1790187210,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7407794b7491d86a5199ad69b599dafd.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b85a1599006e95a59f786b4e50d1993.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc7526c4afdc974079a91e2feab0f743.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da7feb182eff47352bea8fa9cd95cd51.webp",980,1287]